Exome Asset Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Buy
+40,361
New +$247K 0.28% 51
2025
Q4
Sell
-73,614
Closed -$308K 84
2025
Q3
$308K Sell
73,614
-324,232
-81% -$2.07M 0.19% 65
2025
Q2
$3.7M Buy
397,846
+103,000
+35% +$899K 2.75% 10
2025
Q1
$2.87M Buy
294,846
+240,108
+439% +$2.97M 2.56% 16
2024
Q4
$663K Buy
+54,738
New +$665K 0.5% 50

Other funds holding REPL

Exome Asset Management's REPL Position: Q2 2026 in Review

Exome Asset Management opened a new position in Replimune Group (REPL) in Q2 2026: 40,361 shares worth $447K. The stake represents 0.28% of the portfolio and ranks #51 among its holdings. This is a return to the name: Exome Asset Management previously reported a position in REPL as recently as Q3 2025.

Exome Asset Management first reported a position in REPL in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.7M in Q2 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Exome Asset Management held 40,361 shares of Replimune Group worth $447K as of Q2 2026.
  • Replimune Group was a new Exome Asset Management position in Q2 2026.
  • Replimune Group made up 0.28% of Exome Asset Management's portfolio in Q2 2026, its #51 holding.
  • Exome Asset Management first reported a position in Replimune Group in Q4 2024 and has held it in 5 quarters since.
  • Exome Asset Management's Replimune Group position peaked at $3.7M in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.